Latest News

Morningstar (MORN) just announced a $1 billion share repurchase program over the next three years, along with new plans to ramp up operational efficiency and data delivery using AI. Both moves signal management’s intent to strengthen long-term value for investors. See our latest analysis for Morningstar. Morningstar’s latest moves come after a stretch of declining momentum, with the share price down 18.1% in the last quarter and the one-year total shareholder return sitting at -38.9%. Despite...

Stride (LRN) is under heavy legal scrutiny as several investor lawsuits allege the company inflated enrollment numbers and overlooked compliance standards. This increased attention has been accompanied by a sharp negative shift in investor sentiment. See our latest analysis for Stride. This string of legal challenges has weighed heavily on Stride’s share price, with a 90-day share price return of -61.07% and a one-year total shareholder return near -41%. Short-term momentum is clearly fading,...

Belden (BDC) is making waves with a slate of new product launches targeting automation and smart infrastructure. The rollout of advanced networking and security solutions signals a strategic push to stay ahead in these rapidly evolving markets. See our latest analysis for Belden. This wave of innovation comes on the heels of a new board appointment and a fresh dividend affirmation, adding some positive news flow. While Belden’s share price has stumbled over the past quarter and year, with a...

Acuity Brands recently reported its fiscal 2025 fourth quarter results, with revenues rising 17.1% year over year to US$1.21 billion, but slightly missing analyst expectations. While the company exceeded EBITDA targets and grew net sales and margins, it missed organic revenue expectations, providing a mix of strong execution and some areas for improvement. To assess how Acuity's missed revenue estimates alongside strong operational gains may reshape its investment story, let’s review the...

China Everbright (SEHK:165) just wrapped up the second tranche of its 2025 medium-term notes, raising RMB 1.5 billion through a fixed-rate corporate bond. This move reinforces the company’s liquidity and represents another step in its financing activity. See our latest analysis for China Everbright. After a volatile few months, China Everbright’s 1-day share price return of 0.68% and steady performance over the last quarter suggest that investor sentiment is stabilizing as the company shores...

In the past week, Privia Health Group reported third-quarter revenue of US$580.4 million, a 32.5% year-over-year increase that topped analyst expectations by 16.6% as it expanded its technology-enabled services across 13 states and the District of Columbia to more than 4.8 million patients. Despite this strong performance, management issued the weakest full-year guidance among peers, leading some investors to question the outlook for the remainder of the year. We'll examine how the contrast...

Citigroup (C) stock has been drawing some extra attention lately as investors analyze recent performance trends and consider the company’s broader position within the banking sector. The bank’s diversified businesses and steady fundamentals often put it on the radar when market sentiment shifts. See our latest analysis for Citigroup. Citigroup’s share price has been gaining real momentum lately, with the stock closing at $103.6. This reflects a 4.5% share price return over the past month and...

Alight, Inc. announced that Rohit Verma, CEO of Crawford & Company, has been appointed as its next Chief Executive Officer and board member effective January 1, 2026, following the departure of Dave Guilmette on December 31, 2025. Verma brings a track record of strategic leadership and operational expertise, including multiple years of record revenue growth and a focus on client centricity, which aligns with Alight’s emphasis on innovation in benefits administration and employee wellbeing...

Crinetics Pharmaceuticals recently announced that the first patient has been randomized in the pivotal Phase 3 CAREFNDR trial, evaluating once-daily, oral paltusotine in adults with carcinoid syndrome due to well-differentiated neuroendocrine tumors. This milestone reflects the company's effort to expand the use of paltusotine, which is already FDA-approved for acromegaly, into an additional patient population with significant unmet medical needs. We'll explore what the advancement of...

Goldman Sachs recently upgraded Sumitomo Metal Mining from Sell to Neutral and increased its earnings outlook, referencing a revised valuation base year during their analyst update. This shift by a major financial institution highlights evolving sentiment toward the company's projected financial performance and prospects. We'll examine how Goldman Sachs' improved earnings estimates and outlook could influence Sumitomo Metal Mining's investment story. These 13 companies survived and thrived...

US Foods Holding Corp. announced in the past week that its Board of Directors has authorized a share repurchase program of up to US$1 billion. This significant buyback plan reflects management's confidence in the company's outlook and has drawn notable investor attention. Let's explore how the US$1 billion share repurchase could reshape US Foods Holding's investment narrative and market positioning. The end of cancer? These 29 emerging AI stocks are developing tech that will allow early...

Oki Electric Industry (TSE:6703) has rolled out its Projection Assembly System in Thailand and Indonesia, marking the start of its global push in digital transformation solutions for manufacturing. The launch highlights features such as multilingual support and new functionalities, aimed at streamlining assembly and inspection. See our latest analysis for Oki Electric Industry. Oki Electric Industry’s recent move into Southeast Asia comes as momentum has been steadily building behind its...

Comerica (CMA) shares have edged up modestly over the past week, attracting attention from investors who are curious about the bank’s recent performance and what could be driving the stock’s movement this month. See our latest analysis for Comerica. Comerica’s share price has gained notable ground this year, achieving a 30.8% year-to-date return and a 13.9% increase in the past three months. Its one-year total shareholder return of 16.5% shows positive momentum is building after a stretch of...

Organon (OGN) and Shanghai Henlius just received a green light from the FDA for POHERDY, the first pertuzumab biosimilar approved in the US. This move expands their reach in oncology therapies and opens the door for broader access in treating HER2-positive breast cancer. See our latest analysis for Organon. Organon’s latest FDA win arrives after a year of challenging share price momentum, with a 1-year total shareholder return of -50.17% and a steep year-to-date share price return of -48.46%...

American Healthcare REIT (AHR) just completed a public offering, raising nearly $387 million through the sale of 8.1 million shares of its common stock. This fresh capital is planned for general purposes and future investments, making it a meaningful development for current and prospective shareholders. See our latest analysis for American Healthcare REIT. American Healthcare REIT’s share price has surged recently, with a 1-month return of nearly 14% and an impressive 83% share price return...

Shimano (TSE:7309) has called a board meeting for November 18, 2025, with its agenda focused on considering the cancellation of treasury stock, along with other business items. Investors often pay attention to these moves because of their possible long-term impact on shareholder value. See our latest analysis for Shimano. Shimano’s share price briefly rebounded this week, gaining over 8% in the past seven days, as investors responded to talk of a possible treasury stock cancellation and...

Earlier this year, NGL Energy Partners experienced a strong business rebound, highlighted by improved operations and aggressive reductions in debt levels. The water solutions segment, fueled by Delaware Basin drilling, now delivers 85% of EBITDA and supports the company’s stable cash flows. We'll explore how this renewed cash flow strength from water solutions is shaping NGL Energy Partners' overall investment narrative. Outshine the giants: these 25 early-stage AI stocks could fund your...

EchoStar (SATS) shares drew attention after AT&T announced the nationwide deployment of mid-band spectrum acquired from EchoStar. This move focuses on maximizing network potential and monetizing spectrum assets, which matters for investors. See our latest analysis for EchoStar. EchoStar’s rapid appreciation is not just a flash in the pan. Its 18.6% 90-day share price return and eye-catching 222.2% year-to-date gain suggest strong momentum has been building, particularly as the AT&T spectrum...

Earlier this month, Kimco Realty received positive attention after Jim Cramer highlighted the company's high-quality status and attractive dividend yield, shortly after it reported quarterly results that exceeded expectations and raised its full-year funds from operations forecast. An interesting aspect is that, despite this operational momentum and favorable publicity, the company has experienced a 13% decline in its share price for the year to date. We'll explore how Kimco Realty's...

In recent days, Fastly announced its upcoming transition from the New York Stock Exchange to the Nasdaq and disclosed that its Chief Technology Officer sold 40,000 shares. The executive share sale prompted investor concerns about near-term prospects, while the exchange shift underscores Fastly's ongoing transformation strategy. We'll explore how the leadership share sale and focus on transformation may impact Fastly's investment narrative moving forward. AI is about to change healthcare...

Yum! Brands (YUM) has introduced a new set of amendments to its bylaws, concentrating on governance and shareholder meeting procedures. In addition, the company announced plans to accelerate Taco Bell’s growth in Brazil under direct management. See our latest analysis for Yum! Brands. These governance and operational shifts for Yum! Brands have come alongside notable gains, with a 14.7% year-to-date share price return and a robust 12.4% total shareholder return over the past year. This...

In recent weeks, Travere Therapeutics announced that the FDA has modified the Risk Evaluation and Mitigation Strategies (REMS) requirements for FILSPARI, resulting in eased monitoring protocols and improved commercial potential for the drug. This regulatory change is expected to facilitate increased patient access and may support the company's ambitions for label expansion into additional indications such as focal segmental glomerulosclerosis (FSGS). We'll examine how the FDA's REMS...

In late November 2025, UFP Technologies announced recovery plans following workforce turnover at its AJR Illinois facility and revealed ongoing negotiations to expand a significant contract with Intuitive Surgical, with additional investments and new program launches expected. The company also disclosed that two new robotic surgery programs from this collaboration are set to drive more than US$10 million in revenue in 2026, with further opportunities ahead. We’ll explore how the planned...

Oceaneering International (OII) has caught the attention of investors lately, thanks to a recent movement in its stock price and steady month-over-month gains. The company, known for its engineered services for offshore and defense sectors, has delivered a 6% return over the past month. See our latest analysis for Oceaneering International. Oceaneering International’s share price has been edging upward this month, but it is still down about 10% for the year so far. Looking at the bigger...